| CEO: | Phil L'Huillier |
| CFO: | Sath Nirmalananthan |
| Chief Scientific Officer: | Lindy Durrant |
| Deputy Chairman: | Susan Clement Davies |
| Non-Executive Chairman: | Jean-Michel Cosséry |
| Non-Executive Dir: | Martin Diggle , Ursula Ney, Florian Reinaud |
| Address: | Bellhouse Building, Sanders Road, Oxford Science Park, Oxford, United Kingdom , OX4 4GD |
| Website: | http://www.scancell.co.uk/ |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB00B63D3314 |
| Currency | UK Pounds |
| Share Price | 9.45p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 26.25 |
| 52 Week Low | 9.33 |
| Volume | 299,858 |
| Shares Issued | 1,212.23m |
| Market Cap | £114.56m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| Strong Buy | 1 |
| Buy | 1 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 2 |

| No dividends found |
| Time | Volume / Share Price |
| 14:07 | 30,000 @ 9.41p |
| 13:19 | 81,109 @ 9.35p |
| 13:05 | 63,883 @ 9.40p |
| 11:53 | 8,875 @ 9.47p |
| 11:23 | 2,990 @ 9.48p |
| CFO | Sath Nirmalananthan |
| CEO | Phil L'Huillier |
You are here: research